In a big development, pharma majors Cipla and Hetero will soon begin the domestic production of remdesivir, the most promising antiviral drug candidate for the treatment of coronavirus. However, remdesivir has been approved by the Drug Controller General of India (DCGI) only for 'restricted emergency use'.
[ Ссылка ]
Follow us:
Website: [ Ссылка ]
Facebook: [ Ссылка ]
Twitter: [ Ссылка ]
Instagram: [ Ссылка ]
#moneycontrol
